Bone Biologics: First patients treated in Bone Biologics spinal fusion trial
The multicentre trial will see 30 adults with degenerative disc disease treated with the company's NB1 device designed to regenerate bone. The post First patients treated in Bone Biologics spinal fusion trial appeared first on Medical Device Network.
Read full article »
President & CEO
Jeff Frelick
Bone Biologics is a Massachusetts-based medical device company that develops and markets orthobiologic products for osteoporosis and trauma applications.
Read more